オキサゾール化合物及び医薬組成物 - Otsuka Pharmaceutical Co., Ltd.

Title:

オキサゾール化合物及び医薬組成物

Document Type and Number:

Japanese Patent JP5305914

Kind Code:

B2

Abstract:

The present invention provides a oxazole compound represented by Formula (1), or a salt thereof:wherein R1 is an aryl group which may have one or more substituents; R2 is an aryl group or a nitrogen atom-containing heterocyclic group each of which may have one or more substituents; and W is a divalent group represented by —Y1-A1- or —Y2—C(═O)— wherein Y1 is a group such as —C(═O)—, A1 is a group such as a lower alkylene group, and Y2 is a group such as a piperazinediyl group. The oxazole compound has a specific inhibitory action against phosphodiesterase 4.

More Like This:

WO/2010/004228	NOVEL DISCRIMINATING MOLECULE FAMILY FOR NEUTRON AND GAMMA RADIATION
WO/2007/149395	2,5-SUBSTITUTED OXAZOLE DERIVATIVES AS PROTEIN KINASE INHIBITORS FOR THE TREATMENT OF CANCER
JP2003508382	[Title of Invention] A therapeutic method using a phosphate mimetic and a phosphatase inhibitor.

Inventors:

Minoru Okada
Masaya Kato
Norinori Sato
Tetsuyuki Uno
Hideki Kitagaki
Junpei Haruta
Hidetaka Hiyama
Tomonori Shibata

Application Number:

JP2008539670A

Publication Date:

October 02, 2013

Filing Date:

November 14, 2006

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Otsuka Pharmaceutical Co., Ltd.

International Classes:

C07D263/32; A61K31/421; A61K31/422; A61K31/4439; A61K31/4725; A61K31/496; A61K31/497; A61K31/5377; A61P1/04; A61P11/00; A61P11/06; A61P17/00; A61P17/06; A61P17/14; A61P19/02; A61P25/16; A61P25/18; A61P25/22; A61P25/24; A61P25/28; A61P27/02; A61P27/16; A61P29/00; A61P37/08; A61P43/00; C07D263/34; C07D413/06; C07D413/12

Domestic Patent References:

JP2005508961A
JP2004203871A
JP11322730A
JP2001503022A
JP2001519344A

Foreign References:

WO1998008830A1

Attorney, Agent or Firm:

Eiji Saegusa
Mutsuko Nakano
Masahito Hayashi

Previous Patent: 昆虫細胞で産生される改良されたＡＡＶベクター

Next Patent: BOUQUET PACKING DEVICE